@ARTICLE{Hoeft2023-vb,
  title       = "Platelet-instructed {SPP1+} macrophages drive myofibroblast
                 activation in fibrosis in a {CXCL4-dependent} manner",
  author      = "Hoeft, Konrad and Schaefer, Gideon J L and Kim, Hyojin and
                 Schumacher, David and Bleckwehl, Tore and Long, Qingqing and
                 Klinkhammer, Barbara Mara and Peisker, Fabian and Koch, Lars
                 and Nagai, James and Halder, Maurice and Ziegler, Susanne and
                 Liehn, Elisa and Kuppe, Christoph and Kranz, Jennifer and
                 Menzel, Sylvia and Costa, Ivan and Wahida, Adam and Boor,
                 Peter and Schneider, Rebekka K and Hayat, Sikander and
                 Kramann, Rafael",
  affiliation = "Division of Nephrology and Clinical Immunology, RWTH Aachen
                 University, Aachen, Germany; Institute of Experimental
                 Medicine and Systems Biology, RWTH Aachen University, Aachen,
                 Germany. Institute of Experimental Medicine and Systems
                 Biology, RWTH Aachen University, Aachen, Germany. Institute of
                 Experimental Medicine and Systems Biology, RWTH Aachen
                 University, Aachen, Germany; Department of Anesthesiology,
                 RWTH Aachen University, Aachen, Germany. Department of
                 Pathology, RWTH Aachen University, Aachen, Germany. Institute
                 for Computational Genomics, RWTH Aachen University Hospital,
                 Aachen, Germany; Joint Research Center for Computational
                 Biomedicine, RWTH Aachen University Hospital, Aachen, Germany.
                 Institute for Molecular Medicine, University of South Denmark,
                 Odense, Denmark. Institute of Experimental Medicine and
                 Systems Biology, RWTH Aachen University, Aachen, Germany;
                 Department of Urology, RWTH Aachen University, Aachen,
                 Germany; Department of Urology and Kidney Transplantation,
                 Martin-Luther-University, Halle (Saale), Germany. Institute of
                 Metabolism and Cell Death, Helmholtz Zentrum M{\"u}nchen,
                 Neuherberg, Germany; Division of Gynecological Oncology,
                 National Center for Tumor Diseases (NCT), Heidelberg, Germany.
                 Division of Nephrology and Clinical Immunology, RWTH Aachen
                 University, Aachen, Germany; Department of Pathology, RWTH
                 Aachen University, Aachen, Germany. Department of Hematology,
                 Erasmus MC Cancer Institute, Rotterdam, the Netherlands;
                 Department of Cell Biology, Institute for Biomedical
                 Technologies, RWTH Aachen University, Aachen, Germany.
                 Division of Nephrology and Clinical Immunology, RWTH Aachen
                 University, Aachen, Germany; Institute of Experimental
                 Medicine and Systems Biology, RWTH Aachen University, Aachen,
                 Germany; Department of Internal Medicine, Nephrology and
                 Transplantation, Erasmus Medical Center, Rotterdam, the
                 Netherlands. Electronic address: rkramann@gmx.net.",
  abstract    = "Fibrosis represents the common end stage of chronic organ
                 injury independent of the initial insult, destroying tissue
                 architecture and driving organ failure. Here we discover a
                 population of profibrotic macrophages marked by expression of
                 Spp1, Fn1, and Arg1 (termed Spp1 macrophages), which expands
                 after organ injury. Using an unbiased approach, we identify
                 the chemokine (C-X-C motif) ligand 4 (CXCL4) to be among the
                 top upregulated genes during profibrotic Spp1 macrophage
                 differentiation. In vitro and in vivo studies show that loss
                 of Cxcl4 abrogates profibrotic Spp1 macrophage differentiation
                 and ameliorates fibrosis after both heart and kidney injury.
                 Moreover, we find that platelets, the most abundant source of
                 CXCL4 in vivo, drive profibrotic Spp1 macrophage
                 differentiation. Single nuclear RNA sequencing with
                 ligand-receptor interaction analysis reveals that macrophages
                 orchestrate fibroblast activation via Spp1, Fn1, and Sema3
                 crosstalk. Finally, we confirm that Spp1 macrophages expand in
                 both human chronic kidney disease and heart failure.",
  journal     = "Cell Rep.",
  volume      =  42,
  number      =  2,
  pages       = "112131",
  month       =  feb,
  year        =  2023,
  url         = "http://dx.doi.org/10.1016/j.celrep.2023.112131",
  keywords    = "CP: Immunology; CXCL4; PF4; SPP1; SPP1 macrophages; chronic
                 kidney disease; fibrosis; heart failure; innate immunity;
                 myocardial infarction; platelets;1\_reading\_list;0\_Notion",
  language    = "en",
  issn        = "2211-1247",
  pmid        = "36807143",
  doi         = "10.1016/j.celrep.2023.112131",
  pmc         = "PMC9992450"
}

@ARTICLE{Domcke2023-rz,
  title       = "A reference cell tree will serve science better than a
                 reference cell atlas",
  author      = "Domcke, Silvia and Shendure, Jay",
  affiliation = "Department of Genome Sciences, University of Washington School
                 of Medicine, Seattle, WA, USA. Electronic address:
                 domcke@uw.edu. Department of Genome Sciences, University of
                 Washington School of Medicine, Seattle, WA, USA; Brotman Baty
                 Institute for Precision Medicine, Seattle, WA, USA; Allen
                 Discovery Center for Cell Lineage Tracing, Seattle, WA, USA;
                 Howard Hughes Medical Institute, Seattle, WA, USA. Electronic
                 address: shendure@uw.edu.",
  abstract    = "Single-cell biology is facing a crisis of sorts. Vast numbers
                 of single-cell molecular profiles are being generated,
                 clustered and annotated. However, this is overwhelmingly ad
                 hoc, and we continue to lack a principled, unified, and
                 well-moored system for defining, naming, and organizing cell
                 types. In this perspective, we argue against an atlas or
                 periodic table-like discretization as the right metaphor for a
                 reference taxonomy of cell types. In its place, we advocate
                 for a data-driven, tree-based nomenclature that is rooted in a
                 ``consensus ontogeny'' spanning the life cycle of a given
                 species. We explore how such a reference cell tree, inclusive
                 of both lineage histories and molecular states, could be
                 constructed, represented, and segmented in practice. Analogous
                 to the taxonomic classification of species, a consensus
                 ontogeny would provide a universal, stable, and extendable
                 framework for precise scientific communication, both
                 contemporaneously and across the ages.",
  journal     = "Cell",
  volume      =  186,
  number      =  6,
  pages       = "1103--1114",
  month       =  mar,
  year        =  2023,
  url         = "http://dx.doi.org/10.1016/j.cell.2023.02.016",
  keywords    = "1\_reading\_list;0\_Notion",
  language    = "en",
  issn        = "0092-8674, 1097-4172",
  pmid        = "36931241",
  doi         = "10.1016/j.cell.2023.02.016"
}

@UNPUBLISHED{Wang2023-bc,
  title    = "Deep Domain Adversarial Neural Network for the Deconvolution of
              Cell Type Mixtures in Tissue Proteome Profiling",
  author   = "Wang, Fang and Yang, Fan and Huang, Longkai and Song, Jiangning
              and Gasser, Robin B and Aebersold, Ruedi and Wang, Guohua and
              Yao, Jianhua",
  abstract = "Cell type deconvolution is a computational method for the
              determination/resolution of cell type proportions from bulk
              sequencing data, frequently used for the analysis of divergent
              cell types in tumor tissue samples. However, deconvolution
              technology is still in its infancy for the analysis of cell types
              using proteomic data due to challenges with
              repeatability/reproducibility, variable reference standards and
              the lack of single-cell proteomic reference data. Here, we
              developed a novel deep learning-based deconvolution method
              (scpDeconv) tailored to proteomic data. scpDeconv uses an
              autoencoder to leverage the information from bulk proteomic data
              to improve the quality of single-cell proteomic data, and employs
              a domain adversarial architecture to bridge the single-cell and
              bulk data distributions and transfer labels from single-cell data
              to bulk data. Extensive experiments validated the performance of
              scpDeconv in the deconvolution of proteomic data produced from
              various species/sources and different proteomic technologies.
              This method should find broad applicability to areas including
              tumor microenvironment interpretation and clinical
              diagnosis/classification. \#\#\# Competing Interest Statement The
              authors have declared no competing interest.",
  journal  = "bioRxiv",
  pages    = "2022.11.25.517895",
  month    =  jan,
  year     =  2023,
  url      = "https://www.biorxiv.org/content/10.1101/2022.11.25.517895v2",
  keywords = "0\_Notion;Notion\_Notes",
  language = "en",
  doi      = "10.1101/2022.11.25.517895"
}

@ARTICLE{Baker2023-ud,
  title       = "In silico tissue generation and power analysis for spatial
                 omics",
  author      = "Baker, Ethan A G and Schapiro, Denis and Dumitrascu, Bianca
                 and Vickovic, Sanja and Regev, Aviv",
  affiliation = "Klarman Cell Observatory, Broad Institute of MIT and Harvard,
                 Cambridge, MA, USA. Department of Biology, Massachusetts
                 Institute of Technology, Cambridge, MA, USA. Klarman Cell
                 Observatory, Broad Institute of MIT and Harvard, Cambridge,
                 MA, USA. schapirolabor@gmail.com. Laboratory of Systems
                 Pharmacology, Harvard Medical School, Boston, MA, USA.
                 schapirolabor@gmail.com. Institute for Computational
                 Biomedicine, Faculty of Medicine, Heidelberg University
                 Hospital and Heidelberg University, Heidelberg, Germany.
                 schapirolabor@gmail.com. Institute of Pathology, Faculty of
                 Medicine, Heidelberg University Hospital and Heidelberg
                 University, Heidelberg, Germany. schapirolabor@gmail.com.
                 School of Mathematics, Institute of Advanced Study, Princeton,
                 NJ, USA. Department of Computer Science and Technology,
                 University of Cambridge, Cambridge, UK. Klarman Cell
                 Observatory, Broad Institute of MIT and Harvard, Cambridge,
                 MA, USA. svickovic@nygenome.org. New York Genome Center, New
                 York, NY, USA. svickovic@nygenome.org. Department of
                 Biomedical Engineering and Herbert Irving Institute for Cancer
                 Dynamics, Columbia University, New York, NY, USA.
                 svickovic@nygenome.org. Science for Life Laboratory,
                 Department of Immunology, Genetics and Pathology, Beijer
                 Laboratory for Gene and Neuro Research, Uppsala University,
                 Uppsala, Sweden. svickovic@nygenome.org. Klarman Cell
                 Observatory, Broad Institute of MIT and Harvard, Cambridge,
                 MA, USA. aviv.regev.sc@gmail.com. Department of Biology,
                 Massachusetts Institute of Technology, Cambridge, MA, USA.
                 aviv.regev.sc@gmail.com. Genentech, South San Francisco, CA,
                 USA. aviv.regev.sc@gmail.com.",
  abstract    = "As spatially resolved multiplex profiling of RNA and proteins
                 becomes more prominent, it is increasingly important to
                 understand the statistical power available to test specific
                 hypotheses when designing and interpreting such experiments.
                 Ideally, it would be possible to create an oracle that
                 predicts sampling requirements for generalized spatial
                 experiments. However, the unknown number of relevant spatial
                 features and the complexity of spatial data analysis make this
                 challenging. Here, we enumerate multiple parameters of
                 interest that should be considered in the design of a properly
                 powered spatial omics study. We introduce a method for tunable
                 in silico tissue (IST) generation and use it with spatial
                 profiling data sets to construct an exploratory computational
                 framework for spatial power analysis. Finally, we demonstrate
                 that our framework can be applied across diverse spatial data
                 modalities and tissues of interest. While we demonstrate ISTs
                 in the context of spatial power analysis, these simulated
                 tissues have other potential use cases, including spatial
                 method benchmarking and optimization.",
  journal     = "Nat. Methods",
  month       =  mar,
  year        =  2023,
  url         = "http://dx.doi.org/10.1038/s41592-023-01766-6",
  keywords    = "0\_Notion",
  language    = "en",
  issn        = "1548-7091, 1548-7105",
  pmid        = "36864197",
  doi         = "10.1038/s41592-023-01766-6",
  pmc         = "7479520"
}

@ARTICLE{Wunnemann2023-oo,
  title    = "Multimodal {CRISPR} perturbations of {GWAS} loci associated with
              coronary artery disease in vascular endothelial cells",
  author   = "W{\"u}nnemann, Florian and Fotsing Tadjo, Thierry and Beaudoin,
              M{\'e}lissa and Lalonde, Simon and Lo, Ken Sin and Kleinstiver,
              Benjamin P and Lettre, Guillaume",
  abstract = "Genome-wide association studies have identified >250 genetic
              variants associated with coronary artery disease (CAD), but the
              causal variants, genes and molecular mechanisms remain unknown at
              most loci. We performed pooled CRISPR screens to test the impact
              of sequences at or near CAD-associated genetic variants on
              vascular endothelial cell functions. Using CRISPR knockout,
              inhibition and activation, we targeted 1998 variants at 83 CAD
              loci to assess their effect on three adhesion proteins
              (E-selectin, ICAM1, VCAM1) and three key endothelial functions
              (nitric oxide and reactive oxygen species production, calcium
              signalling). At a false discovery rate $\leq$10\%, we identified
              significant CRISPR perturbations near 42 variants located within
              26 CAD loci. We used base editing to validate a putative causal
              variant in the promoter of the FES gene. Although a few of the
              loci include genes previously characterized in endothelial cells
              (e.g. AIDA, ARHGEF26, ADAMTS7), most are implicated in
              endothelial dysfunction for the first time. Detailed
              characterization of one of these new loci implicated the RNA
              helicase DHX38 in vascular endothelial cell senescence. While
              promising, our results also highlighted several limitations in
              using CRISPR perturbations to functionally dissect GWAS loci,
              including an unknown false negative rate and potential off-target
              effects.",
  journal  = "PLoS Genet.",
  volume   =  19,
  number   =  3,
  pages    = "e1010680",
  month    =  mar,
  year     =  2023,
  url      = "http://dx.doi.org/10.1371/journal.pgen.1010680",
  keywords = "0\_Notion",
  language = "en",
  issn     = "1553-7390, 1553-7404",
  pmid     = "36928188",
  doi      = "10.1371/journal.pgen.1010680"
}

% The entry below contains non-ASCII chars that could not be converted
% to a LaTeX equivalent.
@ARTICLE{Wunnemann2021-ji,
  title     = "{CRISPR} perturbations at many coronary artery disease loci
               impair vascular endothelial cell functions",
  author    = "W{\"u}nnemann, F and Tadjo, T F and Beaudoin, M and Lalonde, S
               and {others}",
  abstract  = "Genome-wide association studies have identified 161 genetic
               variants associated with coronary artery disease (CAD), but the
               causal genes and biological pathways remain â€¦",
  journal   = "bioRxiv",
  publisher = "biorxiv.org",
  year      =  2021,
  url       = "https://www.biorxiv.org/content/10.1101/2021.02.10.430527.abstract",
  keywords  = "0\_Notion"
}

@ARTICLE{Mund2022-cs,
  title       = "Unbiased spatial proteomics with single-cell resolution in
                 tissues",
  author      = "Mund, Andreas and Brunner, Andreas-David and Mann, Matthias",
  affiliation = "Proteomics Program, The Novo Nordisk Foundation Center for
                 Protein Research, University of Copenhagen, Faculty of Health
                 and Medical Sciences, Blegdamsvej 3B, 2200 Copenhagen,
                 Denmark. Department of Proteomics and Signal Transduction, Max
                 Planck Institute of Biochemistry, Martinsried, Germany;
                 Boehringer Ingelheim Pharma GmbH \& Co. KG, Drug Discovery
                 Sciences, Birkendorfer Str. 65, D-88397, Biberach Riss,
                 Germany. Proteomics Program, The Novo Nordisk Foundation
                 Center for Protein Research, University of Copenhagen, Faculty
                 of Health and Medical Sciences, Blegdamsvej 3B, 2200
                 Copenhagen, Denmark; Department of Proteomics and Signal
                 Transduction, Max Planck Institute of Biochemistry,
                 Martinsried, Germany. Electronic address:
                 mmann@biochem.mpg.de.",
  abstract    = "Mass spectrometry (MS)-based proteomics has become a powerful
                 technology to quantify the entire complement of proteins in
                 cells or tissues. Here, we review challenges and recent
                 advances in the LC-MS-based analysis of minute protein
                 amounts, down to the level of single cells. Application of
                 this technology revealed that single-cell transcriptomes are
                 dominated by stochastic noise due to the very low number of
                 transcripts per cell, whereas the single-cell proteome appears
                 to be complete. The spatial organization of cells in tissues
                 can be studied by emerging technologies, including multiplexed
                 imaging and spatial transcriptomics, which can now be combined
                 with ultra-sensitive proteomics. Combined with high-content
                 imaging, artificial intelligence and single-cell laser
                 microdissection, MS-based proteomics provides an unbiased
                 molecular readout close to the functional level. Potential
                 applications range from basic biological questions to
                 precision medicine.",
  journal     = "Mol. Cell",
  volume      =  82,
  number      =  12,
  pages       = "2335--2349",
  month       =  jun,
  year        =  2022,
  url         = "http://dx.doi.org/10.1016/j.molcel.2022.05.022",
  keywords    = "0\_Notion;Notion\_Notes",
  language    = "en",
  issn        = "1097-2765, 1097-4164",
  pmid        = "35714588",
  doi         = "10.1016/j.molcel.2022.05.022"
}
